IARS1 and Insulin resistance: None of the treatments significantly affected the expression of IRS-1 (Figure 5A); however, IRS-1pS612 phosphorylation, the hallmark of insulin resistance, was elevated in MOCK-transfected cells in GDB groups by 34.87% (p=0.0203) compared with control conditions.